In the July 12, 2021, issue of Nature Aging, researchers working at the Buck Institute for Research on Aging describe analysis from 1,001 immunomes of generally healthy patients correlating soluble ...
CD8 radiomics signature to assess inter-lesion spatial heterogeneity and cold liver lesions in advanced non-small cell lung cancers treated with durvalumab. Effects of neutralization of tumor-derived ...
An inflammatory-aging clock called developed by Stanford University School of Medicine and the Buck Institute for Research on Aging can predict how strong your immune system will be in 10 years, when ...
Phase II pharmacodynamic trial of palbociclib in patients with KRAS mutant colorectal cancer. This is an ASCO Meeting Abstract from the 2015 Gastrointestinal Cancers Symposium. This abstract does not ...
A new study suggest that using CXCL9 and CXCL10-producing dendritic cells alongside immunotherapy can be a promising strategy to overcome treatment resistance and improve clinical outcomes for ...
In this new analysis, results showed that CCL3, CXCL8, CXCL9, and CXCL10 may be indicators of disease severity. Researchers are shedding light on serum indicators that may be associated with disease ...
Patients with acute tubulointerstitial nephritis (AIN), a difficult-to-diagnose allergic reaction in the kidneys, show substantial increases in the protein CXCL9 in their urine, suggesting an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results